TY - JOUR AU - Burke, W. AU - Evans, B. J. AU - Jarvik, G. P. PY - 2014 DA - 2014// TI - Return of results: ethical and legal distinctions between research and clinical care JO - Am J Med Genet C Semin Med Genet VL - 166C UR - https://doi.org/10.1002/ajmg.c.31393 DO - 10.1002/ajmg.c.31393 ID - Burke2014 ER - TY - JOUR AU - Darnell, A. J. AU - Austin, H. AU - Bluemke, D. A. AU - Cannon, R. O. AU - Fischbeck, K. AU - Gahl, W. PY - 2016 DA - 2016// TI - A clinical service to support the return of secondary genomic findings in human research JO - Am J Hum Genet VL - 98 UR - https://doi.org/10.1016/j.ajhg.2016.01.010 DO - 10.1016/j.ajhg.2016.01.010 ID - Darnell2016 ER - TY - JOUR AU - Husedzinovic, A. AU - Ose, D. AU - Schickhardt, C. AU - Frohling, S. AU - Winkler, E. C. PY - 2015 DA - 2015// TI - Stakeholders’ perspectives on biobank-based genomic research: systematic review of the literature JO - Eur J Hum Genet VL - 23 UR - https://doi.org/10.1038/ejhg.2015.27 DO - 10.1038/ejhg.2015.27 ID - Husedzinovic2015 ER - TY - JOUR AU - Clayton, E. W. AU - McGuire, A. L. PY - 2012 DA - 2012// TI - The legal risks of returning results of genomics research JO - Genet Med VL - 14 UR - https://doi.org/10.1038/gim.2012.10 DO - 10.1038/gim.2012.10 ID - Clayton2012 ER - TY - JOUR AU - Prucka, S. K. AU - Arnold, L. J. AU - Brandt, J. E. AU - Gilardi, S. AU - Harty, L. C. AU - Hong, F. PY - 2015 DA - 2015// TI - An update to returning genetic research results to individuals: perspectives of the industry pharmacogenomics working group JO - Bioethics VL - 29 UR - https://doi.org/10.1111/bioe.12073 DO - 10.1111/bioe.12073 ID - Prucka2015 ER - TY - JOUR AU - McGuire, A. L. AU - Knoppers, B. M. AU - Zawati, M. H. AU - Clayton, E. W. PY - 2014 DA - 2014// TI - Can I be sued for that? Liability risk and the disclosure of clinically significant genetic research findings JO - Genome Res VL - 24 UR - https://doi.org/10.1101/gr.170514.113 DO - 10.1101/gr.170514.113 ID - McGuire2014 ER - TY - JOUR AU - Green, R. C. AU - Berg, J. S. AU - Grody, W. W. AU - Kalia, S. S. AU - Korf, B. R. AU - Martin, C. L. PY - 2013 DA - 2013// TI - ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing JO - Genet Med VL - 15 UR - https://doi.org/10.1038/gim.2013.73 DO - 10.1038/gim.2013.73 ID - Green2013 ER - TY - JOUR AU - Knoppers, B. M. AU - Joly, Y. AU - Simard, J. AU - Durocher, F. PY - 2006 DA - 2006// TI - The emergence of an ethical duty to disclose genetic research results: international perspectives JO - Eur J Hum Genet VL - 14 UR - https://doi.org/10.1038/sj.ejhg.5201690 DO - 10.1038/sj.ejhg.5201690 ID - Knoppers2006 ER - TY - JOUR AU - Knoppers, B. M. AU - Zawati, M. H. AU - Senecal, K. PY - 2015 DA - 2015// TI - Return of genetic testing results in the era of whole-genome sequencing JO - Nat Rev Genet VL - 16 UR - https://doi.org/10.1038/nrg3960 DO - 10.1038/nrg3960 ID - Knoppers2015 ER - TY - JOUR AU - Jarvik, G. P. AU - Amendola, L. M. AU - Berg, J. S. AU - Brothers, K. AU - Clayton, E. W. AU - Chung, W. PY - 2014 DA - 2014// TI - Return of genomic results to research participants: the floor, the ceiling, and the choices in between JO - Am J Hum Genet VL - 94 UR - https://doi.org/10.1016/j.ajhg.2014.04.009 DO - 10.1016/j.ajhg.2014.04.009 ID - Jarvik2014 ER - TY - STD TI - Nuffield Council on Bioethics. Pharmacogenetics: ethical issues. London: Nuffield Foundation; 2003. http://nuffieldbioethics.org/wp-content/uploads/2014/07/Pharmacogenetics-Report.pdf. Accessed 19 Sept 2015. UR - http://nuffieldbioethics.org/wp-content/uploads/2014/07/Pharmacogenetics-Report.pdf ID - ref11 ER - TY - JOUR AU - Fabsitz, R. R. AU - McGuire, A. AU - Sharp, R. R. AU - Puggal, M. AU - Beskow, L. M. PY - 2010 DA - 2010// TI - Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group JO - Circ Cardiovasc Genet VL - 3 UR - https://doi.org/10.1161/CIRCGENETICS.110.958827 DO - 10.1161/CIRCGENETICS.110.958827 ID - Fabsitz2010 ER - TY - STD TI - European Commission. 25 recommendations on the ethical, legal and social implications of genetic testing. Luxembourg: Office for Official Publications of European Communities; 2004. http://bookshop.europa.eu/en/25-recommendations-on-the-ethical-legal-and-social-implications-of-genetictesting-pbKINA21120/downloads/KI-NA-21-120-ENC/KINA21120ENC_002.pdf;pgid=y8dIS7GUWMdSR0EAlMEUUsWb0000PsOdKJz;sid=5VhRDgjRpFlRLFm9X_nPqWr04otX3Q8C44s=?FileName=KINA21120ENC_002.pdf&SKU=KINA21120ENC_PDF&CatalogueNumber=KI-NA-21-120-EN-C. Accessed 11 Oct 2016. UR - http://bookshop.europa.eu/en/25-recommendations-on-the-ethical-legal-and-social-implications-of-genetictesting-pbKINA21120/downloads/KI-NA-21-120-ENC/KINA21120ENC_002.pdf;pgid=y8dIS7GUWMdSR0EAlMEUUsWb0000PsOdKJz;sid=5VhRDgjRpFlRLFm9X_nPqWr04otX3Q8C44s=?FileName=KINA21120ENC_002.pdf&SKU=KINA21120ENC_PDF&CatalogueNumber=KI-NA-21-120-EN-C ID - ref13 ER - TY - JOUR AU - Bois, A. AU - Floquet, A. AU - Kim, J. W. AU - Rau, J. AU - Campo, J. M. AU - Friedlander, M. PY - 2014 DA - 2014// TI - Incorporation of pazopanib in maintenance therapy of ovarian cancer JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2014.55.7348 DO - 10.1200/JCO.2014.55.7348 ID - Bois2014 ER - TY - JOUR AU - Bolton, K. L. AU - Chenevix-Trench, G. AU - Goh, C. AU - Sadetzki, S. AU - Ramus, S. J. AU - Karlan, B. Y. PY - 2012 DA - 2012// TI - Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer JO - JAMA VL - 307 UR - https://doi.org/10.1001/jama.2012.20 DO - 10.1001/jama.2012.20 ID - Bolton2012 ER - TY - JOUR AU - Ledermann, J. AU - Harter, P. AU - Gourley, C. AU - Friedlander, M. AU - Vergote, I. AU - Rustin, G. PY - 2014 DA - 2014// TI - Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial JO - Lancet Oncol VL - 15 UR - https://doi.org/10.1016/S1470-2045(14)70228-1 DO - 10.1016/S1470-2045(14)70228-1 ID - Ledermann2014 ER - TY - JOUR AU - Vencken, P. M. AU - Kriege, M. AU - Hoogwerf, D. AU - Beugelink, S. AU - Burg, M. E. AU - Hooning, M. J. PY - 2011 DA - 2011// TI - Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients JO - Ann Oncol VL - 22 UR - https://doi.org/10.1093/annonc/mdq628 DO - 10.1093/annonc/mdq628 ID - Vencken2011 ER - TY - JOUR AU - Alsop, K. AU - Fereday, S. AU - Meldrum, C. AU - deFazio, A. AU - Emmanuel, C. AU - George, J. PY - 2012 DA - 2012// TI - BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.39.8545 DO - 10.1200/JCO.2011.39.8545 ID - Alsop2012 ER - TY - STD TI - Harter P, Johnson T, Berton-Rigaud D, Park SY, Friedlander M, Del Campo JM, et al. BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR16 study. Gynecol. Oncol. 2016;140(3):443–9. doi:10.1016/j.ygyno.2015.12.027. ID - ref19 ER - TY - JOUR AU - Johns, A. L. AU - Miller, D. K. AU - Simpson, S. H. AU - Gill, A. J. AU - Kassahn, K. S. AU - Humphris, J. L. PY - 2014 DA - 2014// TI - Returning individual research results for genome sequences of pancreatic cancer JO - Genome Med VL - 6 UR - https://doi.org/10.1186/gm558 DO - 10.1186/gm558 ID - Johns2014 ER - TY - JOUR AU - Richards, S. AU - Aziz, N. AU - Bale, S. AU - Bick, D. AU - Das, S. AU - Gastier-Foster, J. PY - 2015 DA - 2015// TI - Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology JO - Genet Med VL - 17 UR - https://doi.org/10.1038/gim.2015.30 DO - 10.1038/gim.2015.30 ID - Richards2015 ER - TY - BOOK PY - 2015 DA - 2015// TI - Breast cancer information core ID - ref22 ER - TY - STD TI - Balmana J, Diez O, Rubio IT, Cardoso F, ESMO Guidelines Working Group. BRCA in breast cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2011;22(suppl 6):vi31–4. doi:10.1093/annonc/mdr373. ID - ref23 ER - TY - JOUR AU - Engel, C. AU - Fischer, C. PY - 2015 DA - 2015// TI - Breast cancer risks and risk prediction models JO - Breast Care (Basel) VL - 10 UR - https://doi.org/10.1159/000376600 DO - 10.1159/000376600 ID - Engel2015 ER - TY - JOUR AU - Gangi, A. AU - Cass, I. AU - Paik, D. AU - Barmparas, G. AU - Karlan, B. AU - Dang, C. PY - 2014 DA - 2014// TI - Breast cancer following ovarian cancer in BRCA mutation carriers JO - JAMA Surg VL - 149 UR - https://doi.org/10.1001/jamasurg.2014.1081 DO - 10.1001/jamasurg.2014.1081 ID - Gangi2014 ER - TY - JOUR AU - Domchek, S. M. AU - Jhaveri, K. AU - Patil, S. AU - Stopfer, J. E. AU - Hudis, C. AU - Powers, J. PY - 2013 DA - 2013// TI - Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer JO - Cancer VL - 119 UR - https://doi.org/10.1002/cncr.27842 DO - 10.1002/cncr.27842 ID - Domchek2013 ER - TY - STD TI - Gonzalez-Martin A, Bover I, Del Campo JM, Redondo A, Vidal L, Spanish Society for Medical Oncology. SEOM guideline in ovarian cancer 2014. Clin Transl Oncol. 2014;16(12):1067–71. doi:10.1007/s12094-014-1229-z. ID - ref27 ER - TY - STD TI - Peterson JF, Field JR, Shi Y, Schildcrout JS, Denny JC, McGregor TL, et al.Attitudes of clinicians following large-scale pharmacogenomics implementation. Pharmacogenomics J. 2016; 16(4):393-8. doi:10.1038/tpj.2015.57. ID - ref28 ER - TY - JOUR AU - Wolf, S. M. AU - Crock, B. N. AU - Ness, B. AU - Lawrenz, F. AU - Kahn, J. P. AU - Beskow, L. M. PY - 2012 DA - 2012// TI - Managing incidental findings and research results in genomic research involving biobanks and archived data sets JO - Genet Med VL - 14 UR - https://doi.org/10.1038/gim.2012.23 DO - 10.1038/gim.2012.23 ID - Wolf2012 ER - TY - STD TI - Bookman T. More People Seek Genetic Testing, But There Aren’t Enough Counselors. Shots-Health News From NPR. http://www.npr.org/sections/health-shots/2016/04/18/473066953/more-people-seek-genetic-testing-but-there-arent-enough-counselors. April 18, 2016. Accessed 23 May 2016. UR - http://www.npr.org/sections/health-shots/2016/04/18/473066953/more-people-seek-genetic-testing-but-there-arent-enough-counselors ID - ref30 ER - TY - JOUR AU - Cheon, J. Y. AU - Mozersky, J. AU - Cook-Deegan, R. PY - 2014 DA - 2014// TI - Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come? JO - Genome Med VL - 6 UR - https://doi.org/10.1186/s13073-014-0121-3 DO - 10.1186/s13073-014-0121-3 ID - Cheon2014 ER - TY - STD TI - Kolata G. When Gene Tests for Breast Cancer Reveal Grim Data but No Guidance. The New York Times. http://www.nytimes.com/2016/03/12/health/breast-cancer-brca-genetic-testing.html?_r=3. March 11, 2016. Accessed 23 May 2016. UR - http://www.nytimes.com/2016/03/12/health/breast-cancer-brca-genetic-testing.html?_r=3 ID - ref32 ER - TY - JOUR AU - Buchanan, A. H. AU - Rahm, A. K. AU - Williams, J. L. PY - 2016 DA - 2016// TI - Alternate service delivery models in cancer genetic counseling: a mini-review JO - Front Oncol VL - 6 UR - https://doi.org/10.3389/fonc.2016.00120 DO - 10.3389/fonc.2016.00120 ID - Buchanan2016 ER - TY - JOUR AU - Viberg, J. AU - Hansson, M. G. AU - Langenskiold, S. AU - Segerdahl, P. PY - 2014 DA - 2014// TI - Incidental findings: the time is not yet ripe for a policy for biobanks JO - Eur J Hum Genet VL - 22 UR - https://doi.org/10.1038/ejhg.2013.217 DO - 10.1038/ejhg.2013.217 ID - Viberg2014 ER - TY - JOUR AU - Soini, S. PY - 2012 DA - 2012// TI - Genetic testing legislation in Western Europe-a fluctuating regulatory target JO - J Community Genet VL - 3 UR - https://doi.org/10.1007/s12687-012-0078-0 DO - 10.1007/s12687-012-0078-0 ID - Soini2012 ER - TY - STD TI - Barnes M, Stayn S, Forster D, Russell-Einhorn M, Peloquin D, Medina-Jordan A. The CLIA/HIPAA Conundrum of Returning Test Results to Research Participants. Bloomberg BNA: Medical Research Law & Policy Report. https://www.ropesgray.com/~/media/Files/articles/2015/July/2015-07-15-Bloomberg-BNA.ashx. Accessed 23 May 2016; 2015. UR - https://www.ropesgray.com/~/media/Files/articles/2015/July/2015-07-15-Bloomberg-BNA.ashx ID - ref36 ER - TY - BOOK PY - 2015 DA - 2015// TI - Attachment C: return of individual results and special considerations of issues arising from amendments of HIPAA and CLIA ID - ref37 ER - TY - JOUR AU - Beskow, L. M. AU - Burke, W. AU - Fullerton, S. M. AU - Sharp, R. R. PY - 2012 DA - 2012// TI - Offering aggregate results to participants in genomic research: opportunities and challenges JO - Genet Med VL - 14 UR - https://doi.org/10.1038/gim.2011.62 DO - 10.1038/gim.2011.62 ID - Beskow2012 ER - TY - JOUR AU - Branum, R. AU - Wolf, S. M. PY - 2015 DA - 2015// TI - International policies on sharing genomic research results with relatives: approaches to balancing privacy with access JO - J Law Med Ethics VL - 43 ID - Branum2015 ER - TY - BOOK PY - 2014 DA - 2014// TI - Regulation (EU) No 536/2014 of the European Parliament And Of The Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing directive 2001/20/EC text with EEA relevance ID - ref40 ER - TY - JOUR AU - Knoppers, B. M. AU - Deschenes, M. AU - Zawati, M. H. AU - Tasse, A. M. PY - 2013 DA - 2013// TI - Population studies: return of research results and incidental findings policy statement JO - Eur J Hum Genet VL - 21 UR - https://doi.org/10.1038/ejhg.2012.152 DO - 10.1038/ejhg.2012.152 ID - Knoppers2013 ER -